2024年8月15日 · Mavyret and Harvoni are both direct-acting antiviral therapies for the treatment of hepatitis C virus (HCV) infection. Mavyret contains glecaprevir and pibrentasvir and is available in the form of tablets or oral pellets.

Compare Harvoni vs Mavyret head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Harvoni (ledipasvir / sofosbuvir) is a combination medication containing two antiviral medications, ledipasvir and sofosbuvir (Sovaldi). It is a first-choice treatment option for hepatitis C for certain types of people. Mavyret (glecaprevir / pibrentasvir) is a combination medication containing two antivirals, glecaprevir and pibrentasvir.

2025年2月4日 · Harvoni (ledipasvir / sofosbuvir) and Mavyret (glecaprevir / pibrentasvir) are both highly effective treatments for hepatitis C, but they have some key differences. Mavyret can treat all six types of hepatitis C, while Harvoni only treats four. In most cases, Mavyret is preferred over Harvoni for treating hepatitis C for the first time.

Harvoni (ledipasvir and sofosbuvir) and Mavyret (glecaprevir and pibrentasvir) are combinations of antiviral agents used to treat chronic hepatitis C (CHC) genotype 1 infection in adults.

2024年5月17日 · Is Mavyret better than Harvoni? Mavyret is reported to have some advantages over Harvoni including the number of hepatitis C virus (HCV) genotypes it covers, the length of treatment required, and the cost of a course of treatment.

2024年10月7日 · Harvoni is a combination of two drugs, ledipasvir and sofosbuvir, that work together to stop the virus from multiplying in the body. Mavyret, on the other hand, is a combination of three drugs – glecaprevir, pibrentasvir, and voxilaprevir – that work together to target different strains of the virus.

Mavyret and Zepatier are contraindicated in patients with moderate to severe hepatic impairment (Child-Pugh B or C) due to potential toxicity. Mavyret is also contraindicated in patients with any history of prior hepatic decompensation (4,7).

2022年7月13日 · Both Mavyret and Harvoni are approved to treat chronic hepatitis C virus (HCV). However, one medication may be more effective for you than the other, depending on the type of HCV you have and ...

glecaprevir/pibrentasvir Mavyret 100mg/40mg tabs ≥12yrs or ≥45kg: 3 tabs once daily with food. ledipasvir/sofosbuvir Harvoni 45mg/200mg, 90mg/400mg tabs ≥3yrs (<17kg): 33.75mg/150mg (pellets)